Prodotto aggiunto correttamente al carrello.

discount label
H-LDEETGEFL-NH2
Visualizzare in 3D

Biosynth logo

H-LDEETGEFL-NH2

Rif. 3D-PP48459

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Martedì 03 Dicembre 2024

Informazioni sul prodotto

Nome:
H-LDEETGEFL-NH2
Descrizione:

Peptide H-LDEETGEFL-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LDEETGEFL-NH2 include the following: Design and synthesis of disulfide-rich peptides with orthogonal disulfide pairing motifs Z Huang, Y Wu, H Dong, Y Zhao - The Journal of Organic , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.joc.0c01600 Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance Y Chen, D Inoyama, ANT Kong - Chemical biology & , 2011 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1747-0285.2011.01240.x Exploring the binding of rationally engineered tandem-repeat proteins to E3 ubiquitin ligase Keap1 SK Madden , LS Itzhaki - Protein Engineering, Design and , 2021 - academic.oup.comhttps://academic.oup.com/peds/article-abstract/doi/10.1093/protein/gzab027/6457287 Small molecule modulators of K eap1-N rf2-ARE pathway as potential preventive and therapeutic agents S Magesh, Y Chen, L Hu - Medicinal research reviews, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/med.21257 Activators and inhibitors of NRF2: a review of their potential for clinical development N Robledinos-Anton - Oxidative medicine , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2019/9372182 The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update MC Lu, JA Ji, ZY Jiang, QD You - Medicinal research reviews, 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/med.21396 Interaction energetics and druggability of the protein-protein interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 M Zhong , A Lynch, SN Muellers, S Jehle, L Luo - Biochemistry, 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biochem.9b00943 Prediction of binding energy of Keap1 interaction motifs in the Nrf2 antioxidant pathway and design of potential high-affinity peptides M Karttunen , WY Choy , EA Cino - The Journal of Physical , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jpcb.8b03295 Inhibiting the Keap1/Nrf2 Protein-Protein Interaction with Protein-Like Polymers KP Carrow, HL Hamilton, MP Hopps, Y Li - Advanced , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.202311467 Virtual screening expands the non-natural amino acid palette for peptide optimization KN Amarasinghe , L De Maria, C Tyrchan - Journal of Chemical , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jcim.2c00193 Combined peptide and small-molecule approach toward nonacidic THIQ inhibitors of the KEAP1/NRF2 interaction JM Ontoria, I Biancofiore, P Fezzardi - ACS Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.9b00594 Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides J Wang, M Zha, Q Fei, W Liu, Y Zhao - Chemistry-A European , 2017 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/chem.201703139 Novel protein-protein interaction inhibitor of Nrf2-Keap1 discovered by structure-based virtual screening HP Sun , ZY Jiang, MY Zhang, MC Lu, TT Yang - , 2014 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2014/md/c3md00240c A Case Study on the Keap1 Interaction with Peptide Sequence Epitopes Selected by the Peptidomic mRNA Display H Hirose , T Hideshima, T Katoh , H Suga - ChemBioChem, 2019 - Wiley Online Libraryhttps://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/cbic.201900039 Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction G Wells - Biochemical Society Transactions, 2015 - portlandpress.comhttps://portlandpress.com/biochemsoctrans/article-abstract/43/4/674/88607 Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents DA Abed, M Goldstein, H Albanyan, H Jin - Acta Pharmaceutica Sinica , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2211383515000829 Strategies for converting turn-motif and cyclic peptides to small molecules for targeting protein-protein interactions D Hayward, AM Beekman - RSC Chemical Biology, 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/cb/d3cb00222e Structural Basis for the Nrf2 interaction with the Keap1 repressor B Padmanabhan, KI Tong, Y Nakamura, A Kobayashi - researchgate.nethttps://www.researchgate.net/profile/Akira-Kobayashi-3/publication/266354656_Structural_Basis_for_the_Nrf2_interaction_with_the_Keap1_repressor/links/55b3215308aed621ddfe17f0/Structural-Basis-for-the-Nrf2-interaction-with-the-Keap1-repressor.pdf

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP48459 H-LDEETGEFL-NH2

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".